Rabipur Rabies vaccine product alert for health professionals
Reports of rubber particles after reconstitution- recommendations to minimise the risk of particles
On 20 August 2024, Bavarian Nordic in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) sent a communication out to customers regarding reports of rubber particles after reconstitution of the Rabipur rabies vaccine.
Recommendations have been provided to minimise the risk of particles. Information and advice is also available on the Valneva website for health professionals - see their direct healthcare professional communication letter here.
An analysis has revealed that these particles consisted of rubber, which was transferred from the rubber stopper of the vaccine vials during the reconstitution process (so called "coring").
Reconstituted Rabipur vaccine should be carefully visually inspected and must not be administered in case of visible particles. The letter contains recommendations on how to perform the reconstitution process, with the aim of minimising the risk of particles caused by "coring".
Health professionals with product quality complaints or clinical enquiries about the Rabipur vaccine should contact the manufacturers (see letter for contact details).
Suspected adverse drug reactions can be reported to the MHRA through the Yellow Card scheme and to Valneva.
Explore more
Marburg virus disease in Ethiopia
On 26 January 2026, the Ministry of Health of Ethiopia declared the end of the Marburg virus disease outbreak
Updated: 05 February 2026ABTA Destinations to Watch report published
ABTA has launched its Destinations to Watch report for 2026
Updated: 03 February 2026Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) until the end of March 2026
Updated: 30 January 2026NaTHNaC Telephone Advice Line for health professionals
Additional advice line sessions are planned, starting in January 2026
Updated: 21 January 2026Country Information updates: Japanese encephalitis vaccine recommendations
NaTHNaC has reviewed and updated the Japanese encephalitis (JE) country-specific information and vaccine recommendations
Updated: 19 January 2026
